ARCHIVES

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

NMP22 Assay More Effective Than Conventional Lab Test

January 27, 2006

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006

Control Finally Gets A Leader–Diane Fink–With An In-House Promotion; NCI Says It Will Spend All The Program’s $34 Million

March 1, 1974

Clinton Signs Bill Creating NIH Center On Minority Health.

December 1, 2000